ID   RMS-GR
AC   CVCL_Y577
DR   Wikidata; Q54950692
RX   PubMed=9685856;
RX   PubMed=10470293;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Doubling time: ~42 hours (PubMed=9685856).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski, Elizabeth I.
RA   Turina, Claire B.
RA   Kikuchi, Ken
RA   Langenau, David M.
RA   Keller, Charles
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=10470293; DOI=10.1111/j.1349-7006.1999.tb00816.x; PMCID=PMC5926126;
RA   Prados, Jose
RA   Melguizo, Consolacion
RA   Marchal, Juan Antonio
RA   Velez, Celia
RA   Alvarez, Luis
RA   Aranega, Antonia
RT   "Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma
RT   cell line obtained after polychemotherapy.";
RL   Jpn. J. Cancer Res. 90:788-793(1999).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183; PMCID=PMC3713458;
RA   Hinson, Ashley R.P.
RA   Jones, Rosanne
RA   Crose, Lisa E.S.
RA   Belyea, Brian C.
RA   Barr, Frederic G.
RA   Linardic, Corinne Mary
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//
RX   PubMed=9685856; DOI=10.1111/j.1349-7006.1998.tb03293.x; PMCID=PMC5921857;
RA   Fernandez-Barbero, Juan Emilio
RA   Prados, Jose
RA   Melguizo, Consolacion
RA   Arena, Nicola
RA   Malavasi, Fabio
RA   Alvarez, Luis
RA   Aranega, Antonia
RT   "Characterization of a new human embryonal rhabdomyosarcoma cell line,
RT   RMS-GR.";
RL   Jpn. J. Cancer Res. 89:525-532(1998).
//